Amy Kramer

1.3k citations
11 papers · 1.0k · h-index 9

Impact in

  • Immunology top 10%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Colorectal Cancer Treatments and Studies 3
    • Cutaneous Melanoma Detection and Management 3
    • Cancer Treatment and Pharmacology 2
    • Melanoma and MAPK Pathways 4
    • Histone Deacetylase Inhibitors Research 1
    • Protein Degradation and Inhibitors 1

Amy Kramer

11 papers receiving 1.0k citations

Peers

Amy Kramer
Comparison fields: 5 of 77
  • Immunology 402
  • Oncology 454
  • Physiology 61
  • Periodontics 36
  • Dermatology 67
Replace Robin Frye with:
Robin Frye United States
You-Hong Fan United States
Paul Vink Netherlands
Stanley Frankel United States
Gerard A. Schellekens Netherlands
P. Joy Ho Australia
Elena Shklovskaya Australia
Bruce A. Robbins United States
Wendy C. Carcamo United States
Grégory Verdeil Switzerland
Amy Kramer relative to Robin Frye United States Robin Frye's profile →
Citations per field
00.5×4.7×
Robin Frye · 1×
Citations per year

Countries citing papers authored by Amy Kramer

Since Specialization
Citations

This map shows the geographic impact of Amy Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Kramer more than expected).

Fields of papers citing papers by Amy Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Kramer. The network helps show where Amy Kramer may publish in the future.

Co-authors

The 25 scholars most cited alongside Amy Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Amy Kramer Line = papers co-authored together Amy Kramer links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1 2007416
2 2014294
3 199395
4 200989
5 200645
6 198939
7 200726
8 200522
9 200410
10 20044
11 20163

About Amy Kramer

Amy Kramer is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Genetics, having authored 11 papers that have together received 1.0k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cutaneous Melanoma Detection and Management (3 papers), Cancer Treatment and Pharmacology (2 papers), Brain Metastases and Treatment (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Immunology (402 citations), Oncology (454 citations), Physiology (61 citations), Periodontics (36 citations) and Dermatology (67 citations). Amy Kramer has collaborated with scholars based in United States, Italy and Germany. Frequent co-authors include Peter J. O’Dwyer, Keith T. Flaherty, Maryann Gallagher, Ravi K. Amaravadi, Katherine L. Nathanson, Andrea B. Troxel, Patricia Sullivan, Scott Antonia, Natalie A. Hutnick and David L. Bajor. Their work appears in journals such as Journal of Clinical Oncology, Autophagy, Journal Of Clinical Periodontology, Clinical Cancer Research and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact